High Altitude Hypoxia Damages Blood Vessels Through Energy Metabolism Disruption
New research reveals how low oxygen at high altitude triggers vascular damage through metabolic changes, offering therapeutic targets.
Summary
Researchers discovered that low oxygen conditions at high altitude damage blood vessel function by disrupting cellular energy production. The study found that oxygen-starved endothelial cells shift from efficient mitochondrial energy production to less efficient glycolysis, producing excess lactate. This lactate buildup triggers a harmful feedback loop that further damages mitochondria and impairs blood vessel relaxation. The findings suggest that targeting this metabolic pathway could prevent altitude-related vascular problems.
Detailed Summary
This groundbreaking study reveals how high-altitude environments damage blood vessels through a previously unknown metabolic mechanism. Understanding this pathway could lead to new treatments for both altitude sickness and cardiovascular diseases involving oxygen deprivation.
Researchers exposed mice to simulated high-altitude conditions (6,000 meters, 9% oxygen) for 45 days and studied isolated blood vessel cells under low-oxygen conditions. They used advanced RNA sequencing and metabolomics to map cellular changes, then tested blood vessel function directly.
The key discovery centers on cellular energy production. Under normal conditions, cells balance two energy pathways: glycolysis (sugar breakdown) and mitochondrial respiration (oxygen-dependent). Hypoxia forces cells to rely heavily on glycolysis, producing excess lactate as a waste product. This lactate then chemically modifies a key enzyme called PKM2 through "lactylation," creating a destructive feedback loop that further damages mitochondria and worsens the metabolic imbalance.
Functional tests showed that hypoxic blood vessels lost their ability to relax properly—a critical function for blood flow regulation. The researchers found decreased levels of eNOS, the enzyme responsible for producing nitric oxide that causes vessel relaxation. Barrier proteins that maintain vessel integrity were also reduced.
Crucially, the team demonstrated that blocking lactate production with sodium dichloroacetate (DCA) or preventing pyruvate entry into mitochondria with UK-5099 could protect vessel function under hypoxic conditions. This suggests the pyruvate-lactate pathway as a therapeutic target for altitude-related cardiovascular problems and potentially other conditions involving tissue oxygen deprivation.
Key Findings
- High altitude hypoxia impairs blood vessel relaxation by 40-60% in mouse studies
- Oxygen deprivation shifts cells from efficient mitochondrial energy to wasteful glycolysis
- Excess lactate chemically modifies PKM2 enzyme, creating harmful metabolic feedback loop
- Blocking lactate production with DCA preserves blood vessel function under hypoxia
- Metabolic pathway disruption precedes and drives vascular endothelial dysfunction
Methodology
Researchers used C57BL/6J mice exposed to simulated 6,000-meter altitude for 45 days, combined with isolated rat and human endothelial cell studies under 5% oxygen. Advanced techniques included RNA sequencing, targeted metabolomics, and direct vessel function testing.
Study Limitations
Study was conducted primarily in rodent models with simulated altitude exposure. Human clinical validation is needed, and the optimal timing and dosing of metabolic interventions requires further investigation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.